Search
for
Sort by
Research 30 of 1000+
- Exogenous Testosterone or Testosterone with Finasteride Increases Bone Mineral Density in Older Men with Low Serum Testosterone
- Effects of Intramuscular Testosterone Undecanoate on Body Composition and Bone Mineral Density in Female-to-Male Transsexuals
- Physical Changes, Laboratory Parameters, and Bone Mineral Density During Testosterone Treatment in Adolescents with Gender Dysphoria
- The long-term effect of specific type II 5alpha-reductase inhibition with finasteride on bone mineral density in men: results of a 4-year placebo controlled trial.
- Antiandrogen Treatment with Spironolactone and Linestrenol Decreases Bone Mineral Density in Eumenorrhoeic Women with Androgen Excess
- A Single Injection of the Anabolic Bone Agent, Parathyroid Hormone–Collagen Binding Domain (PTH–CBD), Results in Sustained Increases in Bone Mineral Density for up to 12 Months in Normal Female Mice
- Bone mineral density in hyperandrogenic amenorrhoea
- Bone mineral density in patients with alopecia areata treated with long-term intralesional corticosteroids.
- Premature Graying, Balding, and Low Bone Mineral Density in Older Women and Men
- Bone Mineral Density is Unaltered in Women with Polycystic Ovary Syndrome
- Changes in bone mineral density in women with early-onset androgenetik alopecia and their correlations with hair-loss stages: a cross-sectional study
- Hair Calcium Concentration is Associated with Calcium Intake and Bone Mineral Density
- The Effect of 5α-Reductase Inhibition With Dutasteride and Finasteride on Bone Mineral Density, Serum Lipoproteins, Hemoglobin, Prostate Specific Antigen and Sexual Function in Healthy Young Men
- The Long-Term Effect Of Specific Type II 5α-Reductase Inhibition With Finasteride on Bone Mineral Density in Men: Results of a 4-Year Placebo Controlled Trial
- The solar window hypothesis: androgenetic alopecia as an evolutionary adaptation to maintain bone mineral density in vitamin D receptor low-efficiency variants
- The Long-Term Effect Of Specific Type II 5??-Reductase Inhibition With Finasteride on Bone Mineral Density in Men: Results of a 4-Year Placebo Controlled Trial
- Bone Metabolism in Patients with Hidradenitis Suppurativa: A Case-control Study
- The influence of ESR1 polymorphisms on selected hormonal, metabolic and mineral balance markers in women with hyperandrogenism
- Dissection of genetic variation and evidence for pleiotropy in male pattern baldness
- First-in-human phase 1 study of ETC-159 an oral PORCN inhbitor in patients with advanced solid tumours.
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- Effects of lifelong testosterone exposure on health and disease using Mendelian randomization
- Androgen treatment of postmenopausal women
- The rationale for physiological testosterone replacement in women
- Gonadal Suppressive and Cross‐Sex Hormone Therapy for Gender Dysphoria in Adolescents and Adults
- Male hormonal contraception: looking back and moving forward
- Betaine supplementation is less effective than methionine restriction in correcting phenotypes of CBS deficient mice
- Safety aspects of androgen treatment with 5α-dihydrotestosterone
- The Safety of Testosterone Therapy in Women
- Parathyroid hormone linked to a collagen binding domain promotes hair growth in a mouse model of chemotherapy-induced alopecia in a dose-dependent manner